We are live on ! Find out more
USNA icon

Usana Health Sciences

136 hedge funds and large institutions have $636M invested in Usana Health Sciences in 2016 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 36 increasing their positions, 67 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

2.94% less ownership

Funds ownership: 91.69%88.75% (-2.9%)

16% less funds holding

Funds holding: 161136 (-25)

46% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 67

69% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 36

73% less capital invested

Capital invested by funds: $2.36B → $636M (-$1.72B)

Holders
136
Holders Change
-25
Holders Change %
-15.53%
% of All Funds
3.62%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
11
Increased
36
Reduced
67
Closed
36
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$88.3M -$5.53M -93,966 -6%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$85.4M -$76.2K -1,294 -0.1%
Vanguard Group
3
Vanguard Group
Pennsylvania
$79M +$1.3M +22,090 +2%
Schroder Investment Management Group
4
Schroder Investment Management Group
United Kingdom
$43.8M +$10.4M +176,200 +32%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$41M -$209K -3,546 -0.5%
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
$25.1M +$426K +7,228 +2%
BIT
7
BlackRock Institutional Trust
California
$17.2M -$252K -4,282 -1%
Morgan Stanley
8
Morgan Stanley
New York
$16.5M +$3.37M +57,218 +27%
BFA
9
BlackRock Fund Advisors
California
$15.8M -$1.53M -26,068 -9%
NAP
10
New Amsterdam Partners
New York
$13.4M -$1.55M -26,366 -11%
State Street
11
State Street
Massachusetts
$11.6M +$105K +1,784 +0.9%
Bank of New York Mellon
12
Bank of New York Mellon
New York
$11.4M +$637K +10,814 +6%
TA
13
Teachers Advisors
New York
$10.6M +$2.41M +40,992 +31%
Northern Trust
14
Northern Trust
Illinois
$9.94M +$175K +2,972 +2%
RFC
15
Russell Frank Company
Washington
$9.01M -$2M -34,020 -19%
Norges Bank
16
Norges Bank
Norway
$8.54M
MCM
17
Matarin Capital Management
New York
$8.52M +$546K +9,274 +7%
HA
18
Hays Advisory
Tennessee
$8.01M -$1.01M -17,156 -12%
Ameriprise
19
Ameriprise
Minnesota
$7.16M +$1.57M +26,642 +29%
Millennium Management
20
Millennium Management
New York
$6.88M -$740K -12,562 -10%
AQR Capital Management
21
AQR Capital Management
Connecticut
$6.43M +$1.56M +26,432 +33%
AP
22
AHL Partners
United Kingdom
$6.15M +$5.03M +85,400 +539%
Arrowstreet Capital
23
Arrowstreet Capital
Massachusetts
$5.3M -$12.4M -210,820 -71%
TCIM
24
TIAA CREF Investment Management
New York
$5.3M -$43.8K -744 -0.8%
Allianz Asset Management
25
Allianz Asset Management
Germany
$4.78M -$1.35M -23,000 -23%

USNA Hedge Fund Activity: Q1 2016 in Review

136 of the 3,754 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q1 2016, worth a combined $636M — down 73% from $2.36B a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of USNA and 11 opened new positions — a net loss of 25 holders — while 67 trimmed existing stakes and 36 added.

The largest buyer was Schroder Investment Management Group, adding an estimated $10.4M. The largest seller was Arrowstreet Capital, cutting an estimated $12.4M.

  • 136 institutional investors held Usana Health Sciences (USNA) as of Q1 2016, down from 161 in Q4 2015.
  • Funds reported $636M of Usana Health Sciences stock for Q1 2016, down 73% quarter-over-quarter.
  • 11 funds opened new Usana Health Sciences positions in Q1 2016 and 36 closed out, a net change of -25 holders.
  • The largest Usana Health Sciences buyer in Q1 2016 was Schroder Investment Management Group, an estimated $10.4M added.
  • The largest Usana Health Sciences seller in Q1 2016 was Arrowstreet Capital, an estimated $12.4M sold.

Based on aggregated 13F filings for Q1 2016.